[Combined anti-EGFR and anti-HER2 monoclonal antibodies: preclinical efficacy in the treatment of pancreatic cancer].

Source:http://linkedlifedata.com/resource/pubmed/id/17937885

Download in:

View as

General Info

PMID
17937885